THC and its metabolites can remain detectable in the body long after the psychoactive effects have worn off. Detection windows vary enormously depending on the test type, usage pattern, body composition, and the specific cutoff thresholds applied. This article covers the pharmacokinetics behind detection and the practical timelines for each test modality.
THC-COOH Pharmacokinetics
THC (delta-9-tetrahydrocannabinol) is metabolised in the liver via CYP450 enzymes into two primary metabolites:
- 11-OH-THC - psychoactive, produced during first-pass metabolism, the primary metabolite found in faeces.
- THC-COOH (11-nor-9-carboxy-THC) - non-psychoactive, the primary metabolite detected in urine drug screens.
THC-COOH is what immunoassay urine tests actually measure. It has a much longer elimination half-life than THC itself, which is why urine tests detect use days to weeks after the last dose even though the subjective effects lasted only hours.
Lipophilicity and Fat Storage
THC is highly lipophilic - it partitions rapidly from blood into fat tissue during use and is then released slowly back into the bloodstream over days to weeks. This is fundamentally different from water-soluble drugs, which are cleared relatively quickly by the kidneys.
The practical consequence: detection windows for THC are not primarily determined by how much was consumed on the last occasion, but by the cumulative body burden stored in adipose tissue. A single use adds little to fat stores. Years of daily use create a large reservoir that takes weeks or months to fully clear.
Detection Windows by Test Type
Urine Testing
Urine immunoassays are the most common drug screening method. Standard cutoff is 50 ng/mL for the initial screen, with confirmation testing at 15 ng/mL by GC-MS or LC-MS/MS.
| Usage Pattern | Approximate Detection Window |
|---|---|
| Single use | Up to 3 days |
| Moderate use (4 times/week) | 5–7 days |
| Chronic daily use | 10–15 days |
| Heavy chronic use (multiple times/day) | 30+ days |
Blood Testing
THC in blood peaks 6–20 minutes after inhalation and drops rapidly as THC redistributes into tissues.
- Typical detection window: 2–12 hours after a single use.
- Heavy chronic users: THC can remain detectable in blood for up to 30 days, due to slow release from fat stores back into the bloodstream.
Blood tests are better at detecting recent impairment but are poor indicators of long-term use patterns.
Saliva Testing
Saliva tests detect parent THC (not metabolites) deposited in the oral mucosa during smoking or vaping.
- Single or occasional use: detectable for up to 24 hours.
- Frequent daily use: detectable for up to 72 hours.
Saliva tests have a narrow detection window and are primarily used for roadside impairment testing, not retrospective use assessment.
Hair Testing
Hair follicle tests measure THC-COOH incorporated into the hair shaft via the bloodstream during the growth phase.
- Standard detection window: up to 90 days.
- Hair grows approximately 0.5 inches per month; a standard 1.5-inch sample covers roughly 3 months of history.
- Body hair grows more slowly and may represent longer windows.
Hair tests cannot determine when within the window use occurred, only that it occurred. They are also subject to false positives from external contamination (secondhand smoke, handling) and have higher rates of false negatives for light or infrequent use.
Cutoff Levels
Drug test results depend critically on the cutoff concentration applied. Different testing contexts use different thresholds:
| Test Type | Initial Screen Cutoff | Confirmation Cutoff |
|---|---|---|
| Urine (SAMHSA/federal) | 50 ng/mL (THC-COOH) | 15 ng/mL (GC-MS) |
| Blood | 1–5 ng/mL (THC) | Varies by jurisdiction |
| Saliva | 4 ng/mL (THC) | 2 ng/mL |
| Hair | 1 pg/mg (THC-COOH) | 0.1 pg/mg |
Factors Affecting Clearance
Several variables determine where an individual falls within the detection window ranges:
- Body fat percentage. Higher adiposity means a larger reservoir for THC storage and slower elimination. BMI is a reasonable proxy, though not a perfect one - distribution of fat matters.
- Frequency and duration of use. Daily users accumulate far more THC in fat stores than occasional users. Years of daily use create body burdens that take weeks to fully clear.
- Potency of products used. Higher-THC products (concentrates, modern high-potency flower) deliver more THC per session, increasing the cumulative body burden.
- Metabolic rate. Individual variation in CYP450 enzyme activity, overall metabolic rate, and liver function all influence the speed of THC-COOH production and elimination.
- Hydration and renal function. While hydration does not meaningfully speed THC metabolite elimination, severely dehydrated individuals may produce more concentrated urine samples that exceed cutoff thresholds more easily.
- Exercise. Physical activity can mobilise THC from fat stores, temporarily increasing blood and urine levels. This effect is counterproductive near test dates. Exercise does not accelerate overall elimination.
Common Misconceptions
Several widely circulated methods for accelerating THC clearance lack evidence:
- Detox drinks and kits. No reliable evidence supports their efficacy. Some work by diluting urine, which can itself trigger an invalid result (measured by creatinine levels). Excessive water consumption to dilute urine can cause dangerous hyponatraemia.
- Cranberry juice, niacin, vinegar. No pharmacological mechanism for accelerating THC-COOH elimination. These are folk remedies with no clinical support.
- Sauna or steam rooms. THC is not meaningfully excreted through sweat. The primary elimination route is hepatic metabolism followed by renal and faecal excretion.
- Intense exercise before a test. Counterproductive. Lipolysis releases stored THC into the bloodstream, potentially increasing urine metabolite concentrations in the short term.
The only reliable method for clearing THC from the body is abstinence and time.
Practical Considerations
For heavy chronic users, a conservative estimate is 30–60 days for a negative urine test at the standard 50 ng/mL cutoff. Home urine test kits (available at pharmacies) can be used to track progress. Results should be confirmed at the same cutoff level as the anticipated formal test.
Blood and saliva tests have much shorter detection windows and are less relevant for pre-employment or clinical screening contexts, where urine testing dominates.
Hair testing is difficult to beat through abstinence alone if use occurred within the growth window of the sampled hair, but it is used far less frequently than urine testing.
References
- Huestis, M. A. (2007). Human cannabinoid pharmacokinetics. Chemistry & Biodiversity, 4(8), 1770–1804.
- Sharma, P., Murthy, P., & Bharath, M. M. (2012). Chemistry, metabolism, and toxicology of cannabis: clinical implications. Iranian Journal of Psychiatry, 7(4), 149–156.
- SAMHSA. (2020). Mandatory Guidelines for Federal Workplace Drug Testing Programs. Substance Abuse and Mental Health Services Administration.
- Goodwin, R. S., et al. (2008). Urinary elimination of 11-nor-9-carboxy-Δ9-tetrahydrocannabinol in cannabis users during continuously monitored abstinence. Journal of Analytical Toxicology, 32(8), 562–569.